Latest filing published 25 Jun 2024 for Sarepta Therapeutics, Inc., €361k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ryan Edward Brown: trading record in brief
Ryan Edward Brown, listed as board member, appears in our data through filings on Sarepta Therapeutics, Inc. shares, published by SEC (Form 4). Between 28 February 2021 and 25 June 2024, the trades on record add up to 32 filings.
Every open-market trade on record is a sale: 8 sales worth €6.1M. The rest of the record consists of 22 share grants and 2 option exercises. Since January 2024: no purchases and 8 sales on the market.
The newest entry dates from 25 June 2024: an open-market sale of €1.1M, in Sarepta Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ryan Edward Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,352 shares@ US$164.644.3% of flowCommon StockSEC:0000950170-24-077522:1
- 23,500 shares@ US$62.7716.6% of flowCommon StockSEC:0000950170-24-077522:2
- 7,644 shares@ US$158.0713.6% of flowCommon StockSEC:0000950170-24-077522:3
- 2,200 shares@ US$159.143.9% of flowCommon StockSEC:0000950170-24-077522:4
- 975 shares@ US$160.311.8% of flowCommon StockSEC:0000950170-24-077522:5
- 4,168 shares@ US$161.827.6% of flowCommon StockSEC:0000950170-24-077522:6
- 17,581 shares@ US$162.6532.1% of flowCommon StockSEC:0000950170-24-077522:7
- 3,840 shares@ US$163.537.1% of flowCommon StockSEC:0000950170-24-077522:8
- 6,250 sharesCommon StockSEC:0000950170-24-077522:0
- 2,549 shares@ US$164.524.7% of flowCommon StockSEC:0000950170-24-077522:9
- 506 shares@ US$120.490.7% of flowCommon StockSEC:0000950170-24-029530:0
- 1,734 shares@ US$125.322.4% of flowCommon StockSEC:0000950170-24-027495:0
- 269 shares@ US$126.190.4% of flowCommon StockSEC:0000950170-24-026609:0
- 89 shares@ US$123.600.1% of flowCommon StockSEC:0001209191-23-034676:0
- 635 shares@ US$153.191.1% of flowCommon StockSEC:0001209191-23-018019:0
- 1,154 shares@ US$157.212.1% of flowCommon StockSEC:0001209191-23-017400:0
- 196 shares@ US$147.570.3% of flowCommon StockSEC:0001209191-23-016057:0
- 54 shares@ US$72.670.0002% mcap3.5% of flowCommon StockSEC:0001209191-22-034380:0
- 1,136 shares@ US$79.201.0% of flowCommon StockSEC:0001209191-22-017346:0
- 184 shares@ US$75.050.1% of flowCommon StockSEC:0001209191-22-014407:0
- 64 shares@ US$76.010.0% of flowCommon StockSEC:0001209191-21-037727:0
21 of 21 declarations
